StartsideNATCOPHARM • NSE
add
Natco Pharma Ltd.
Forrige sluttkurs
1 389,20 ₹
Dagsintervall
1 365,60 ₹ - 1 403,85 ₹
Årsintervall
724,20 ₹ - 1 639,00 ₹
Markedsverdi
250,57 mrd. INR
Gjennomsnittlig volum
843,82k
P/E-tall
15,31
Utbytte
0,39 %
Hovedbørs
NSE
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(INR) | juni 2024info | Endring år til år |
---|---|---|
Omsetning | 13,63 mrd. | 19,47 % |
Driftskostnader | 4,22 mrd. | 3,11 % |
Nettoomsetning | 6,68 mrd. | 59,05 % |
Netto resultatmargin | 49,06 | 33,13 % |
Fortjeneste per aksje | 37,32 | 60,45 % |
EBITDA | 8,07 mrd. | 40,06 % |
Faktisk avgiftssats | 16,81 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
(INR) | juni 2024info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 18,49 mrd. | 59,13 % |
Totale aktiva | — | — |
Totale passiva | — | — |
Total egenkapital | 58,53 mrd. | — |
Utestående aksjer | 179,13 mill. | — |
P/B-forhold | 4,25 | — |
Avkastning på aktiva | — | — |
Avkastning på kapital | 30,55 % | — |
Kontantstrøm
Netto kontantstrøm
(INR) | juni 2024info | Endring år til år |
---|---|---|
Nettoomsetning | 6,68 mrd. | 59,05 % |
Kontantstrøm fra drift | — | — |
Kontanter fra investering | — | — |
Kontanter fra finansiering | — | — |
Netto kontantstrøm | — | — |
Fri kontantstrøm | — | — |
Om
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad with a presence in formulation and active pharmaceutical ingredients in both domestic and international markets. The company also manufactures Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. The company has a presence in 50+ countries. NATCO is a science driven company and focuses on limited competition molecules in the US .The company’s pharma division has 5 manufacturing facilities, 2 API and intermediate manufacturing facilities and the crop health sciences division has one formulation and one technical manufacturing facility. The company boasts of having a talent pool of 450+ scientists working out of two research centers in India.
Across the globe, cancer treatment saw a sea change in early 2000s in terms of screening, diagnosis, molecular pathology, targeted therapies, immunotherapies, Bone Marrow Transplants, and supportive care. Wikipedia
Administrerende direktør
Grunnlagt
1981
Hovedkvarter
Nettsted
Ansatte
4 016